IMMI, backed by AstraZeneca: 2014 requests for proposals on 'the ultra-rapid diagnosis of resistance to antibiotics' and 'the characterisation of new antibiotic targets'

Backed by AstraZeneca, IMMI is launching two requests for proposals in the field of antibiotic resistance on the 'ultra-rapid diagnosis of resistance to antibiotics' and 'the characterisation of new antibiotic targets'.

Full applications including all information required for scientific, technical and financial evaluation of projects must be submitted electronically to the following address no later than midnight of Wednesday 30 April 2014: institutMMI@inserm.fr
The results of the request for proposals will be published on 30 June 2014.

Download the text of the request for proposals, the financial appendices, the administrative form and the scientific form.